Olaparib cocrystal forms (Nuformix)

N/A

Report date: 2025/05/20 17:40:08

Base Information

Drug NameOlaparib cocrystal forms (Nuformix)
Drug Alias NameNXP004NXP-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNuformix PLC
China Registration ClassN/A

Develop Information

Active CompaniesNuformix PLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A